Make us your home page
Instagram

Jabil's hint of downturn drops stock, as analysts fret its Apple business may slow

ST. PETERSBURG — Global electronics manufacturer Jabil posted second-quarter earnings Wednesday that inspired CEO Mark Mondello to say he was "pleased" with the results but prompted analysts to fret that the company may be losing momentum

The chief concern: Apple.

Jabil makes cases and other parts for Apple's hugely successful iPhones, among other products. Apple has ranked as one of Jabil's chief customers for years and remains a key reason behind its growth.

Jabil shares fell 1.2 percent over the past year but dropped 8 percent to $20.20 in after-hours trading Wednesday.

"I'm pleased to report second-quarter results that were largely in line with our guidance and expectations," Mondello said. While praising the "outstanding" performance of one of Jabil's business segments, he added a cautionary remark about Jabil's "DMS", or "diversified manufacturing segment" — Jabil-speak for the business that includes Apple. That segment, he said, "grew modestly as we faced a slight downturn in product demand late in our fiscal quarter specific to our mobility business."

For the next quarter, Jabil projected core profit of 12 to 18 cents a share — sharply lower than analyst estimates — on $4.1 billion to $4.3 billion in revenue, with diversified manufacturing services revenue projected to fall 10 percent from the same period last year. At this pace, Jabil is now likely to hit $18.5 billion in revenues for this year, while earlier being on track to top $20 billion.

In Wednesday's second-quarter announcement, Jabil reported net income of $78.9 million on revenues of $4.4 billion. It remains one of Tampa Bay's largest public companies with more than 140,000 employees across two dozen countries.

Jabil's hint of downturn drops stock, as analysts fret its Apple business may slow 03/16/16 [Last modified: Wednesday, March 16, 2016 7:49pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...
  1. Massachusetts firm buys Tampa's Element apartment tower

    Real Estate

    TAMPA — Downtown Tampa's Element apartment tower sold this week to a Massachusetts-based real estate investment company that plans to upgrade the skyscraper's amenities and operate it long-term as a rental community.

    The Element apartment high-rise at 808 N Franklin St. in downtown Tampa has been sold to a Northland Investment Corp., a Massachusetts-based real estate investment company. JIM DAMASKE  |  Times
  2. New York town approves Legoland proposal

    News

    GOSHEN, N.Y. — New York is one step closer to a Lego dreamland. Goshen, a small town about fifty miles northwest of the Big Apple, has approved the site plan for a $500 million Legoland amusement park.

    A small New York town, Goshen approved the site plan for a $500 million Legoland amusement park. Legoland Florida is in Winter Haven. [Times file  photo]
  3. Jordan Park to get $20 million makeover and new senior housing

    Real Estate

    By WAVENEY ANN MOORE

    Times Staff Writer

    ST. PETERSBURG —The St. Petersburg Housing Authority, which bought back the troubled Jordan Park public housing complex this year, plans to spend about $20 million to improve the 237-unit property and construct a new three-story building for …

    Jordan Park, the historic public housing complex, is back in the hands of the St. Petersburg Housing Authority. The agency is working to improve the 237-unit complex. But the latest plan to build a new three-story building for seniors will mean 31 families have to find new homes. [LARA CERRI   |   Tampa Bay Times]
  4. Coming soon at two Tampa Bay area hospitals: a cancer treatment that could replace chemo

    Health

    A new cancer treatment that could eventually replace chemotherapy and bone marrow transplants — along with their debilitating side effects — soon will be offered at two of Tampa Bay's top-tier hospitals.

    Dr. Frederick Locke at Moffitt Cancer Center in Tampa is a principal investigator for an experimental therapy that retrains white blood cells in the body's immune system to fight cancer cells. The U.S. Food and Drug Administration approved these so-called "CAR-T" treatments for adults this month. In trials, 82 percent of cases responded well to the treatment, and 44 percent are still in remission at least eight months later, Locke said. [CHRIS URSO   |   Times]
  5. Regulator blasts Wells Fargo for deceptive auto insurance program

    Banking

    Wells Fargo engaged in unfair and deceptive practices, failed to properly manage risks and hasn't set aside enough money to pay back the customers it harmed, according to a confidential report by federal regulators.

    Wells Fargo engaged in unfair and deceptive practices, failed to properly manage risks and hasn't set aside enough money to pay back the customers it harmed, according to a confidential report by federal regulators.
[Photo by Spencer Platt/Getty Images, 2017]